These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. A randomized controlled clinical trial on piperacillin/tazobactam versus ticarcillin/clavulanic acid for the treatment of bacterial infections. Hou F, Li J, Gao L, Chen Y. Chin Med J (Engl); 1998 Nov; 111(11):1039-43. PubMed ID: 11189212 [Abstract] [Full Text] [Related]
5. Results of the North American trial of piperacillin/tazobactam compared with clindamycin and gentamicin in the treatment of severe intra-abdominal infections. Investigators of the Piperacillin/Tazobactam Intra-abdominal Infection Study Group. Eur J Surg Suppl; 1994 Nov; (573):61-6. PubMed ID: 7524798 [Abstract] [Full Text] [Related]
6. Comparative evaluation of the in vitro activity of three combinations of beta-lactams with beta-lactamase inhibitors: piperacillin/tazobactam, ticarcillin/clavulanic acid and ampicillin/sulbactam. Sader HS, Tosin I, Sejas L, Miranda E. Braz J Infect Dis; 2000 Feb; 4(1):22-8. PubMed ID: 10788842 [Abstract] [Full Text] [Related]
7. Treatment of skin and soft-tissue infections. File TM, Tan JS. Am J Surg; 1995 May; 169(5A Suppl):27S-33S. PubMed ID: 7755165 [Abstract] [Full Text] [Related]
8. Piperacillin/tazobactam compared with ticarcillin/clavulanate in community-acquired bacterial lower respiratory tract infection. Shlaes DM, Baughman R, Boylen CT, Chan JC, Charan NB, Cormier YC, Erickson A, Grossman R, Kirmani N, Suh B. J Antimicrob Chemother; 1994 Oct; 34(4):565-77. PubMed ID: 7868408 [Abstract] [Full Text] [Related]
9. Piperacillin and tazobactam versus clindamycin and gentamicin in the treatment of hospitalized women with pelvic infection. The Piperacillin/tazobactam Study Group. Sweet RL, Roy S, Faro S, O'Brien WF, Sanfilippo JS, Seidlin M. Obstet Gynecol; 1994 Feb; 83(2):280-6. PubMed ID: 8290195 [Abstract] [Full Text] [Related]
10. Treating diabetic foot infections with sequential intravenous to oral moxifloxacin compared with piperacillin-tazobactam/amoxicillin-clavulanate. Lipsky BA, Giordano P, Choudhri S, Song J. J Antimicrob Chemother; 2007 Aug; 60(2):370-6. PubMed ID: 17553812 [Abstract] [Full Text] [Related]
12. Pharmacokinetics and tissue penetration of piperacillin/tazobactam with particular reference to its potential in abdominal and soft tissue infections. Sörgel F, Kinzig M. Eur J Surg Suppl; 1994 Aug; (573):39-44. PubMed ID: 7524794 [Abstract] [Full Text] [Related]
14. Piperacillin/tazobactam versus imipenem/cilastatin in the treatment of intra-abdominal infections. Niinikoski J, Havia T, Alhava E, Pääkkönen M, Miettinen P, Kivilaakso E, Haapiainen R, Matikainen M, Laitinen S. Surg Gynecol Obstet; 1993 Mar; 176(3):255-61. PubMed ID: 8382381 [Abstract] [Full Text] [Related]
18. Population pharmacokinetics and pharmacodynamics of piperacillin/tazobactam in patients with complicated intra-abdominal infection. Li C, Kuti JL, Nightingale CH, Mansfield DL, Dana A, Nicolau DP. J Antimicrob Chemother; 2005 Aug; 56(2):388-95. PubMed ID: 16002420 [Abstract] [Full Text] [Related]